Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03998813
Other study ID # CHD038-19
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2, 2020
Est. completion date April 8, 2024

Study information

Verified date April 2024
Source Centre Hospitalier Departemental Vendee
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The prevalence of Chronic Post-Surgical Pain (CPSP) after knee replacement, defined as pain greater than or equal to 4/10 on the visual analogue scale after the third postoperative month, is recognised as high, with an average of 20% (extremes of 7 to 45%). These CPSP, when present, cause poor long-term joint functional prognosis and impaired quality of life for patients. Many predictive, pre-, per- and post-operative factors of these CPSP have been identified in recent years. The most common postoperative risk factor found in the literature is the intensity of early pain. The treatment protocols for this early post-surgical pain are currently and mainly multimodal in nature, combining systemic analgesics (paracetamol, NSAIDs, morphine, gabapentins) and local anaesthetics, administered either in the form of peripheral nerve blocks (continuous or single injection) or in the form of tissue infiltration (TI) performed by the surgeon during the operation. Very few of these techniques have been evaluated for their ability to reduce the incidence of CPSP. Drugs with antihyperalgesic properties such as ketamine or nefopam have been shown to be of no interest, except to reduce the proportion of pain of a neuropathic nature. Only the continuous femoral block has shown, to date, an interest in IT to reduce the incidence of these CPSP. The main objective of this study is to show that a multimodal analgesia protocol based on continuous locoregional analgesia by femoral triangle catheterization could reduce the incidence of chronic post surgical pain compared to a protocol based on tissue infiltration.


Recruitment information / eligibility

Status Completed
Enrollment 287
Est. completion date April 8, 2024
Est. primary completion date June 26, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Adult patient; - Placement of unilateral tricompartmental knee prosthesis for gonarthrosis; - ASA score between I and III ; - Nonseptic scheduled surgery; - Knee replacement scheduled on one of the first 3 days of the week (Monday to Wednesday included) in order to benefit from a homogeneous postoperative physical therapy; - Able to understand the protocol; - Having agreed to participate in the study and having given express oral consent; - Affiliated with a social security system; - Possibility of being followed as part of the protocol. Exclusion Criteria: - Age >= 86 years old; - BMI > 35 ; - Revision of knee replacement; - Symptomatic contralateral osteoarthritis; - Anterior of surgery on the operated knee (excluding arthroscopy and meniscectomy); - Vascular surgery on the femoral vessels on the operated side; - Concept of diffuse polyalgia syndrome (fibromyalgia); - Documented neuropathy of the lower limb; - Localized infection at the catheter puncture site (femoral triangle); - Known allergy to Ropivacaine; - Renal insufficiency (Clearance - CKD-EPI formula - creatinine <30 ml/min) and/or severe hepatic insufficiency (prothrombin blood level <50%) ; - Inflammatory rheumatic disease (rheumatoid arthritis, ankylosing spondylitis...) ; - Patients on immunosuppressive or systemically administered corticosteroid therapy; - Daily use of level II or III analgesics for more than one month pre-operatively; - Known intolerance to tier III analgesics; - Allergy or contraindications to standard treatments administered per and postoperatively (paracetamol, NSAIDs); - Patient undergoing knee surgery in the year prior to inclusion and participating in the study; - Patients who do not cooperate or do not understand French, difficulties in understanding and evaluating the pain score, preoperative cognitive dysfunction making the interview unreliable; - Patient under guardianship, curators, deprivation of liberty; - Patient already engaged in another interventional clinical study (category 1); - Pregnant or breastfeeding women, or women in a position to procreate who refuse an effective means of contraception; - Refusal to participate; - Inability to understand the protocol and its requirements, and/or to give express oral consent.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ropivacaine
Locoregional analgesia by femoral triangle catheterization
Ropivacaine
Tissue infiltration

Locations

Country Name City State
France Clinique Victor PAUCHET Amiens
France Centre Hospitalier de Béthune Beuvry Béthune
France Centre Hospitalier Départemental Vendée La Roche-sur-Yon
France Hôpital des Diaconesses Croix Saint Simon Paris
France Hôpital Privé Sévigné Rennes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Departemental Vendee

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary A walking pain assessment scale greater than or equal to 4 Self-assessment scale to quantify the patient's pain on a virtual scale from 0 (no pain) to 10 (maximum pain imaginable) Three months from the intervention
See also
  Status Clinical Trial Phase
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Completed NCT06049303 - Paraffin Wax Bath With Joint Mobilization Technique in Post-traumatic Stiff Knee N/A
Not yet recruiting NCT05062499 - The Effects of Home Use of Transcutaneous Electrical Nerve Stimulation on People With Knee OA and or Chronic Knee Pain N/A
Not yet recruiting NCT06466330 - Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial N/A
Active, not recruiting NCT03211663 - Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
Completed NCT04146311 - Effect of Short-term Motor Training on Accuracy and Precision of Knee Movement in Human With and Without Knee Pain N/A
Completed NCT03364088 - Outcome After Total Knee Arthroplasty Under General or Spinal Anesthesia N/A
Recruiting NCT06197958 - Comparison of Concentric-eccentric Exercises in Patellofemoral Pain Syndrome N/A
Recruiting NCT06239649 - The Effect of RF Genicular Nerve Block Applied in the Preoperative Period on Fast-track Total Knee Arthroplasty
Completed NCT03545048 - Effects of Internet / Web-based Exercises on the Population With Knee Arthritis N/A
Recruiting NCT05596591 - Focused Extracorporeal Shockwave Therapy for Knee Arthritis N/A
Completed NCT05551000 - Functional Training to Improve Everyday Performance in Elderlies N/A
Active, not recruiting NCT05908942 - Genicular RFT vs Phenol Management in Patients With Knee Osteoarthritis
Recruiting NCT04989023 - Clinical Applications of Blood Flow Restriction and Rehabilitation Outcomes N/A
Completed NCT03337243 - Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis N/A
Terminated NCT04620525 - Cognition, Pain and Wellbeing
Completed NCT04443452 - Molecular Pathways Involved in Knee Pain
Recruiting NCT04148807 - Effectiveness of a Walking Intervention on Impact Loading and Pain N/A
Recruiting NCT06038240 - Optimizing Pain Self-Management in Total Knee Arthroplasty N/A
Recruiting NCT06094660 - RFA or Chemical Neurolysis of the Genicular Nerves Compared to Conservative Treatment for Knee Pain Caused by OA N/A